Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Eupraxia Pharmaceuticals Announces Change of Auditor
      Biotech

      Eupraxia Pharmaceuticals Announces Change of Auditor

      September 8, 2023
      Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury
      Biotech

      Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury

      September 7, 2023
      Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT217 for Small Cell Lung Cancer and Other Neuroendocrine Cancers Expressing DLL3
      Biotech

      Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT217 for Small Cell Lung Cancer and Other Neuroendocrine Cancers Expressing DLL3

      September 7, 2023
      New one-year results for Kodiak’s tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion
      Biotech

      New one-year results for Kodiak’s tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion

      September 7, 2023
      Launch of We Venture Capital
      Biotech

      Launch of We Venture Capital

      September 7, 2023
      Ariceum Therapeutics doses first patient with its first-in-class targeted radiopharmaceutical drug satoreotide in its Phase Ib study in small cell lung cancer
      Biotech

      Ariceum Therapeutics doses first patient with its first-in-class targeted radiopharmaceutical drug satoreotide in its Phase Ib study in small cell lung cancer

      September 7, 2023
      Bühler and NRGene collaborate to increase competitiveness of black soldier fly industry
      Biotech

      Bühler and NRGene collaborate to increase competitiveness of black soldier fly industry

      September 6, 2023
      CANbridge to Participate in Two Investor Conferences in September
      Biotech

      CANbridge to Participate in Two Investor Conferences in September

      September 6, 2023
      Tetra Pharm Technologies concludes preclinical testing of TPT0301 in preparation of First-in-Human clinical trials
      Biotech

      Tetra Pharm Technologies concludes preclinical testing of TPT0301 in preparation of First-in-Human clinical trials

      September 6, 2023
      IDEAYA Biosciences to Participate in Upcoming September 2023 Investor Relations Events
      Biotech

      IDEAYA Biosciences to Participate in Upcoming September 2023 Investor Relations Events

      September 5, 2023
      « 1 … 102 103 104 105 106 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026